Create MedicinalProductIndication

POST {{fhir_url}}/MedicinalProductIndication

Request Params

Request Body

{"resourceType"=>"MedicinalProductIndication", "id"=>"example", "text"=>{"status"=>"generated", "div"=>"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div>"}, "diseaseSymptomProcedure"=>{"coding"=>[{"system"=>"http://ema.europa.eu/example/indicationasdisease-symptom-procedure", "code"=>"Venousthromboembolismprophylaxis"}], "text"=>"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."}, "comorbidity"=>[{"coding"=>[{"system"=>"http://ema.europa.eu/example/comorbidity", "code"=>"Hipsurgery"}]}], "intendedEffect"=>{"coding"=>[{"system"=>"http://ema.europa.eu/example/intendedeffect", "code"=>"PRYLX"}]}, "population"=>[{"ageRange"=>{"low"=>{"value"=>18, "unit"=>"a"}}}]}